Vertebral fractures in patients with chronic obstructive pulmonary disease: The EOLO Study

Osteoporosis International

Volumn 20, Issue 6, 2009, Pages 989-998

  Nuti, R ^a   Siviero, P ^b   Maggi, S ^b   Guglielmi, G ^c   Caffarelli, C ^a   Crepaldi, G ^b   Gonnelli, S ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Scientific Institute   (Italy)

Author keywords

COPD; Glucocorticoids; Quantitative ultrasound; Vertebral fractures

Indexed keywords

GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR; THORAX RADIOGRAPHY; VERTEBRA FRACTURE;

FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; ITALY; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SPINAL FRACTURES;

EID: 67349263016     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-008-0770-4     Document Type: Article

References (38)

1. KF Rabe S Hurd A Anzueto 2007 Global initiative for chronic obstructive lung disease global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 15 176 532 555
2. EF Wouters MP Celis MK Breyer 2007 Co-morbid manifestations in COPD Respir Med: COPD update 3 135 151
3. DM Biskobing 2002 COPD and osteoporosis Chest 121 609 620
4. AA Ionescu E Schoon 2003 Osteoporosis in chronic obstructive pulmonary disease Eur Respir J 22 Suppl 46 64s 75s
5. O Gluck G Colice 2004 Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases Chest 125 1859 1876
6. JP Praet A Peretz S Rozenberg 1992 Risk of osteoporosis in men with chronic bronchitis Osteoporos Int 2 257 261
7. F Iqbal J Michaelson L Thaler 1999 Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function Chest 116 1616 1624
8. TP Van Staa HG Leufkens L Abenhaim 2000 Use of oral corticosteroids and risk of fractures J Bone Miner Res 15 993 1000
9. The Lung Health Study Research Group 2000 Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease N Engl J Med 343 1902 1909
10. RA Pauwels CG Löfdahl LA Laitinen 1999 Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society study on chronic obstructive pulmonary disease N Engl J Med 340 1948 1953
11. M Sosa P Saavedra C Valero GIUMO Study Group 2006 Inhaled steroids do not decrease bone mineral density but increase risk of fractures: data from the GIUMO Study Group J Clin Densitom 9 154 158
12. A Kjensli P Mowinckel MS Ryg 2007 Low bone mineral density is related to severity of chronic obstructive pulmonary disease Bone 40 493 497
13. A Vrieze MH de Greef PJ Wijkstra 2007 Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass Osteoporos Int 18 1197 1202
14. H Katsura K Kida 2002 A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma Chest 122 1949 1955
15. RA Incalzi P Caradonna P Ranieri 2000 Correlates of osteoporosis in chronic obstructive pulmonary disease Respir Med 94 1079 1084
16. HP Dimai W Domej G Leb 2001 Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia J Bone Miner Res 16 2132 2141
17. MA Vermeeren EC Creutzberg AM Schols on behalf of the COSMIC Study Group 2006 Prevalence of nutritional depletion in a large out-patient population of patients with COPD Respir Med 100 1349 1355
18. A Papaioannou W Parkinson N Ferko 2003 Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada Osteoporos Int 14 913 917
19. C Schlaich HW Minne T Bruckner 1998 Reduced pulmonary function in patients with spinal osteoporotic fractures Osteoporos Int 8 261 267
20. DM Kado WS Browner L Palermo 1999 Vertebral fractures and mortality in older women: a prospective study. Study of osteoporotic fractures research group Arch Intern Med 159 1215 1220
21. JA Riancho J Gonzalez Macias C Del Arco 1987 Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease Thorax 42 962 966
22. CE [tmp] McEvoy KE Ensrud E Bender 1998 Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 704 709
23. F de Vries TP van Staa MS Bracke 2005 Severity of obstructive airway disease and risk of osteoporotic fracture Eur Respir J 25 879 884
24. NR Jørgensen P Schwarz I Holme 2007 The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study Respir Med 101 177 185
25. F de Vries M Bracke HG Leufkens 2007 Fracture risk with intermittent high-dose oral glucocorticoid therapy Arthritis Rheum 56 208 214
26. P Vestergaard L Rejnmark L Mosekilde 2007 Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids Chest 132 1599 1607
27. Guglielmi G, Stoppino LP, Placentino MG et al. (2007) Reproducibility of a semi-automatic method for 6-point vertebral morphometry in a multi-centre trial. Eur J Radiol. Published online December 8 doi: 10.1016/j.ejrad.2007.09. 040
28. HK Genant CY Wu C van Kuijk 1993 Vertebral fracture assessment using a semiquantitative technique J Bone Miner Res 8 1137 1148
29. MA Krieg R Barkmann S Gonnelli 2008 Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions J Clin Densitom 11 163 187
30. TW O'Neill D Felsenberg J Varlow 1996 The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study J Bone Miner Res 11 1010 1018
31. A Angeli G Guglielmi A Dovio 2006 High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study Bone 39 253 259
32. S Lekamwasam DP Trivedi KT Khaw 2002 An association between respiratory function and bone mineral density in women from the general community: a cross sectional study Osteoporos Int 13 710 715
33. N Bonnet CL Benhamou B Brunet-Imbault 2005 Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats Bone 37 622 633
34. F de Vries S Pouwels M Bracke 2007 Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study Pharmacoepidemiol Drug Saf 16 612 619
35. P Vestergaard L Rejnmark L Mosekilde 2007 Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids Chest 132 1599 607
36. TP van Staa HG Leufkens C Cooper 2001 Use of inhaled corticosteroids and risk of fractures J Bone Miner Res 16 581 588
37. F de Vries S Pouwels JW Lammers 2007 Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study J Intern Med 261 170 177
38. J Huopio H Kröger R Honkanen 2004 Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women Osteoporos Int 15 190 195